Gussyup LLC dba Private Label Grooming – 709488

by Pill Pals Customer Service | Aug 12, 2025 | News

Delivery Method: VIA UPS Reference #: 320-25-90 Product: Drugs Recipient: Recipient Name Mr. Neal Flowers Recipient Title President Gussyup LLC dba Private Label Grooming 7360 Eastgate Rd, Suite 135Henderson, NV 89011-4091United States Issuing Office: Center for Drug...

Rapidly Progressing Melioidosis Outbreak in City Center Zoo, Hong Kong, 2024

by Pill Pals Customer Service | Aug 11, 2025 | News

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Government of the Hong Kong Special Administrative Region, Hong Kong,...

Detection of Rat Lungworms in Invasive Mollusks, Georgia, USA, 2024

by Pill Pals Customer Service | Aug 11, 2025 | News

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Middle Georgia State University, Macon, Georgia, USA (T.J. Achatz, C.H....

Neuhaus Issues Allergy Alert on Undeclared Wheat in Belgian Chocolate Moments Smurf’s Popping Milk Chocolates with Cookies’

by Pill Pals Customer Service | Aug 11, 2025 | News

Summary Company Announcement Date: August 08, 2025 FDA Publish Date: August 10, 2025 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Undeclared wheat allergen Company Name: Neuhaus Chocolates NV Brand Name: Product...

DermaRite Industries Issues Voluntary Nationwide Recall of DermaKleen, Dermasarra, Kleenfoam, and Perigiene Products Due to Burkholderia cepacia Contamination

by Pill Pals Customer Service | Aug 9, 2025 | News

Summary Company Announcement Date: August 08, 2025 FDA Publish Date: August 09, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Contamination with Burkholderia cepacia Company Name: DermaRite Industries, LL Brand Name: Brand Name(s)...

FDA grants accelerated approval to zongertinib for non-squamous NSCLC

by Pill Pals Customer Service | Aug 8, 2025 | News

On August 8, 2025, the Food and Drug Administration granted accelerated approval to zongertinib (Hernexeos, Boehringer Ingelheim Pharmaceuticals, Inc.), a kinase inhibitor, for adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC)...

Regulatory Policy Information

by Pill Pals Customer Service | Aug 8, 2025 | News

1/6/2025Final GuidanceInterim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic ActN/A1/6/2025Final GuidanceInterim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug,...

Report on the State of Pharmaceutical Quality

by Pill Pals Customer Service | Aug 8, 2025 | News

Everyone deserves confidence in their next dose of medicine. A quality medicine is safe, effective, and available for the people who need it. The Office of Pharmaceutical Quality’s mission is to assure that quality medicines are available to the American public. Drug...

EIND Applications for Antiviral Products

by Pill Pals Customer Service | Aug 8, 2025 | News

Note: The following information is to be used by physicians who would like to request an Emergency IND for an antiviral product regulated by the Center for Drug Evaluation and Research (CDER)/Division of Antivirals (DAV). DAV regulates products that are being...